Calliditas Therapeutics AB (publ) (CALTX.ST)
SEK 208.0
(0.87%)
SEK 208.0
(0.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Billion | 802.87 Million | 229.34 Million | 874 Thousand | 184.82 Million | - |
| Cost of Revenue | 77.05 Million | 15.2 Million | - | - | - | 51 Thousand |
| Gross Profit | 1.12 Billion | 787.67 Million | 229.34 Million | 874 Thousand | 184.82 Million | -51 Thousand |
| Operating Expenses | 1.51 Billion | 1.2 Billion | 753.8 Million | 383.09 Million | 212.7 Million | 133.19 Million |
| Selling, General and Administrative Expenses | 1.01 Billion | 774.65 Million | 390.23 Million | 141.72 Million | 62.88 Million | 133.14 Million |
| Research and Development Expenses | 499.53 Million | 414.74 Million | 357.48 Million | 241.37 Million | 149.82 Million | 99.26 Million |
| Other Expenses | -7.11 Million | 20.21 Million | 6.08 Million | - | - | 51 Thousand |
| Cost and Expenses | 1.59 Billion | 1.22 Billion | 753.8 Million | 383.09 Million | 212.7 Million | 133.19 Million |
| Operating Income | -384.39 Million | -421.94 Million | -524.45 Million | -379.72 Million | -28.01 Million | -132.48 Million |
| Interest Expense | 73.19 Million | 12.52 Million | 7.1 Million | 393 Thousand | 325 Thousand | 8000.00 |
| Income Tax Expense | 9.16 Million | 2.85 Million | -3.83 Million | 360 Thousand | 77 Thousand | 441 Thousand |
| Earnings before Tax | -457.01 Million | -409.41 Million | -513.37 Million | -436.15 Million | -32.5 Million | -132.04 Million |
| Net Income | -466.18 Million | -412.26 Million | -509.53 Million | -436.51 Million | -32.57 Million | -132.04 Million |
| Earnings Per Share Basic | -8.69 | -7.78 | -10.02 | -9.73 | -0.88 | -2.54 |
| Earnings Per Share Diluted | -8.69 | -7.78 | -10.02 | -9.73 | -0.88 | -2.54 |
| Weighted Average Shares Outstanding | 53.67 Million | 53.02 Million | 50.82 Million | 44.87 Million | 36.94 Million | 51.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.67 Million | 53.02 Million | 50.82 Million | 44.87 Million | 36.94 Million | 51.89 Million |
| Gross Margin | 0.94 | 0.98 | 1.00 | 1.00 | 1.00 | - |
| EBIT Margin | -0.30 | -0.53 | -2.29 | -433.47 | -0.14 | - |
| Profit Margin | -0.39 | -0.51 | -2.22 | -499.44 | -0.18 | - |
| EBITDA | -367.8 Million | -358.83 Million | -469.68 Million | -432.93 Million | -30.35 Million | -130.34 Million |
| Earnings Before Tax Margin | -0.32 | -0.53 | -2.29 | -434.46 | -0.15 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 559.78 Million | 295.48 Million | 451.56 Million | 1.2 Billion | 294.59 Million | 269.38 Million |
| Cost of Revenue | 53.44 Million | 14.01 Million | 22.29 Million | 77.05 Million | 14.92 Million | 14.21 Million |
| Gross Profit | 506.33 Million | 281.46 Million | 429.26 Million | 1.12 Billion | 279.67 Million | 255.17 Million |
| Operating Expenses | 540.53 Million | 485.29 Million | 399.84 Million | 1.51 Billion | 439.24 Million | 330.34 Million |
| Selling, General and Administrative Expenses | 419.81 Million | 342.16 Million | 293.16 Million | - | 259.17 Million | 268.62 Million |
| Research and Development Expenses | 120.71 Million | 150.61 Million | 106.67 Million | - | 179.9 Million | 88.98 Million |
| Other Expenses | -2.69 Million | - | - | - | - | - |
| Cost and Expenses | 593.97 Million | 499.3 Million | 422.14 Million | 1.59 Billion | 454.16 Million | 344.55 Million |
| Operating Income | -34.19 Million | -203.82 Million | 29.41 Million | -384.39 Million | -159.57 Million | -75.17 Million |
| Interest Expense | 11.15 Million | 43.49 Million | 56.02 Million | 73.19 Million | 4.5 Million | - |
| Income Tax Expense | 4.81 Million | -1.16 Million | 4.11 Million | 9.16 Million | 4.27 Million | 21.27 Million |
| Earnings before Tax | -42.66 Million | -247.32 Million | -14.25 Million | -457.01 Million | -164.08 Million | -70.66 Million |
| Net Income | -47.47 Million | -246.16 Million | -18.36 Million | -466.18 Million | -168.35 Million | -91.93 Million |
| Earnings Per Share Basic | -0.88 | -4.59 | -0.34 | - | -3.14 | -1.71 |
| Earnings Per Share Diluted | -0.88 | -4.59 | -0.34 | - | -3.14 | -1.71 |
| Weighted Average Shares Outstanding | 53.68 Million | 53.67 Million | 53.67 Million | 53.67 Million | 53.67 Million | 53.67 Million |
| Weighted Average Shares Outstanding (Diluted) | 53.68 Million | 53.67 Million | 53.67 Million | 53.67 Million | 53.67 Million | 53.67 Million |
| Gross Margin | 0.90 | 0.95 | 0.95 | 0.94 | 0.95 | 0.95 |
| EBIT Margin | -0.06 | -0.69 | 0.07 | - | -0.54 | -0.28 |
| Profit Margin | -0.08 | -0.83 | -0.04 | -0.39 | -0.57 | -0.34 |
| EBITDA | -31.5 Million | -203.82 Million | 29.41 Million | - | -159.57 Million | -75.17 Million |
| Earnings Before Tax Margin | -0.06 | -0.69 | 0.07 | -0.32 | -0.54 | -0.28 |
SCYT
600415
1440
ADVIKCA
SCNLF
ORCH